Figure 3.

Increase in CD38+DR+ CD8⁺ T Cells 5 Days after scIL-2 Therapy Initiation. Cytograms of CD38 and DR expression on CD8⁺ T cells during a single cycle of scIL-2. Both the percentage of CD38DR^bright cells increases as well as the MFI of CD38 on the whole population. (CD38 MFI DAY 0 = 7.41, DAY 5 = 20.9, DAY 30 = 7.46)